Low-dose diazepam can increase social competitiveness

July 18, 2017
Credit: CC0 Public Domain

Psychologists speak of anxiety in two forms: "state" anxiety, which refers to anxiety arising from a particular situation; and "trait" anxiety, which refers to anxiety as part of a person's overall personality. Studies have shown that high trait anxiety can seriously hamper a person's ability to compete in a social context, thus putting "highly anxious" individuals in a circle of social disadvantage and more anxiety. Now EPFL scientists have shown that low doses of anxiolytic drugs - such as diazepam (Valium) - can ameliorate this effect by increasing the activity of mitochondria in the neurons of a brain pathway associated with motivation and reward. The work is published in Molecular Psychiatry.

Anxiety and anxiolytics

Some people tend to be relaxed while others are perpetually worried and tense. The difference is what psychologists call "trait ", and studies have shown that can have significant consequences on social life. Specifically, trait anxiety can undermine a person's confidence in competing for social standing, making them feel overlooked and rejected: a condition psychologists call "social subordination".

Previous studies have suggested anxiolytic drugs—for example the benzodiazepines, which include diazepam—could perhaps help relieve anxiety-related social subordination, but the evidence has been scarce, and the idea was virtually dismissed by the scientific community.

Anxiolytics unshackle mitochondria

The lab of Carmen Sandi at EPFL, which has long history of research in trait anxiety, now shows that low doses of diazepam helps high-anxious rats overcome their social competition disadvantage. The scientists also found that it helped medium-anxious rats increase their ability to compete socially. On the other hand, low-dose diazepam did not help low-anxious rats increase their already higher social competitiveness.

Wanting to connect this behavioral change to neuroscience, the researchers also looked at the neural circuits it involves. Specifically, they focused on two regions of the brain: First, the ventral tegmental area (VTA), which is one of the brain regions where diazepam is known to act. Second, the nucleus accumbens, which receives input from the VTA, and which the lab has previously shown to be heavily involved in trait anxiety and social competitiveness. Both regions are known to be involved the processing of motivation and reward.

The scientists showed that diazepam increases the release of the neurotransmitter dopamine from VTA neurons to the nucleus accumbens. The increased dopamine acts on specialized receptors on the nucleus accumbens neurons (D1 dopaminergic receptors), and activates them. These in turn trigger a biochemical cascade that increases the activity and energy output of the neurons' mitochondria—the cell's powerhouses.

Specifically, the mitochondria increase their "respiration", which is the set of metabolic reactions that break down glucose and turn it into ATP, the cell's energy molecule. In short, increases ATP in the neurons of the , and this ultimately enhances the individual's ability to compete socially.

The work establishes the role of anxiolytics in combating social subordination and, more critically, shows that mitochondrial function is a promising target for drug treatment of anxiety-related social dysfunctions.

"Using a pharmacological approach, we could reveal here key neural mechanisms whereby individuals can rapidly and transiently experience changes in their self-confidence and competitive capacities," says Carmen Sandi. "However, similar changes in mitochondrial function could also be achieved through behavior-training programs or nutritional interventions." Her group is already researching effective, non-pharmacological interventions that target the same mechanisms in the brain to ameliorate behavioral dysfunctions related to trait anxiety.

Explore further: Anxiety can kill your social status

More information: M.A. van der Kooij, F. Hollis, L. Lozano, I. Zalachoras, S. Abad, O. Zanoletti, J. Grosse, I. Guillot de Suduiraut, C. Canto, C. Sandi. Diazepam actions in the VTA enhance social dominance and mitochondrial function in the nucleus accumbens by activation of dopamine D1 receptors. Molecular Psychiatry 18 July 2017. DOI: 10.1038/MP.2017.135

Related Stories

Anxiety can kill your social status

December 1, 2015
Neuroscientists at EPFL identify a brain region that links anxious temperament to low social status. The researchers were able to tweak social hierarchy in animals by using vitamin B3.

Mitochondria, an exciting new target for the treatment of anxiety disorders

December 16, 2015
One third of patients with anxiety disorders do not respond to currently available anxiolytic treatments. In their latest study, scientists at the Max Planck Institute of Psychiatry in Munich have shown for the first time ...

How stress can lead to inequality

February 18, 2015
Stress is a staple of our lives today, and we know intuitively that it can influence our confidence in competing with others. But how exactly does stress do that? Scientists at EPFL have carried out the first behavioral study ...

Study links brain structure, anxiety and negative bias in healthy adults

April 13, 2017
Healthy college students who have a relatively small inferior frontal cortex - a brain region behind the temples that helps regulate thoughts and emotions - are more likely than others to suffer from anxiety, a new study ...

Just made a bad decision? Perhaps anxiety is to blame

March 15, 2016
Most people experience anxiety in their lives. For some, it is just a bad, passing feeling, but, for many, anxiety rules their day-to-day lives, even to the point of taking over the decisions they make.

Recommended for you

Encouraging risk-taking in children may reduce the prevalence of childhood anxiety

December 13, 2017
A new international study suggests that parents who employ challenging parent behavioural (CPB) methods – active physical and verbal behaviours that encourage children to push their limits – are likely protecting their ...

Anti-stress compound reduces obesity and diabetes

December 13, 2017
For the first time, scientists from the Max Planck Institute of Psychiatry in Munich could prove that a stress protein found in muscle has a diabetes promoting effect. This finding could pave the way to a completely new treatment ...

Researchers link epigenetic aging to bipolar disorder

December 12, 2017
Bipolar disorder may involve accelerated epigenetic aging, which could explain why persons with the disorder are more likely to have - and die from - age-related diseases, according to researchers from The University of Texas ...

Researchers find common psychological traits in group of Italians aged 90 to 101

December 12, 2017
In remote Italian villages nestled between the Mediterranean Sea and mountains lives a group of several hundred citizens over the age of 90. Researchers at the University of Rome La Sapienza and University of California San ...

Twitter can reveal our shared mood

December 11, 2017
In the largest study of its kind, researchers from the University of Bristol have analysed mood indicators in text from 800 million anonymous messages posted on Twitter. These tweets were found to reflect strong patterns ...

New therapy can help schizophrenia sufferers re-engage socially

December 11, 2017
A new therapy aimed at helping young people suffering from schizophrenia to reconnect and engage with the world around them has had promising results, according to a new University of Sussex-led study.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.